combin
molecularbiolog
techniqu
increas
understand
effect
gene
sequenc
modif
viral
function
yellow
fever
positivestrand
rna
viru
vaccin
manipul
induc
protect
immun
respons
virus
famili
eg
japanes
enceph
dengu
virus
trigger
emerg
west
nile
viru
infect
new
world
afflict
human
hors
bird
success
recombin
technolog
prompt
rapid
develop
liveviru
attenu
candid
vaccin
west
nile
viru
yellow
fever
liveattenu
vaccin
yf
vaccin
strain
develop
year
ago
empir
method
includ
substanti
passag
histori
vaccin
use
widescal
immun
children
tropic
area
travel
militari
personnel
long
experi
million
peopl
provid
assur
safeti
efficaci
make
yellow
fever
ideal
vector
foreign
gene
howev
disadvantag
practic
positivestrand
viru
high
rate
genet
variat
caus
viral
replic
polymeras
without
proofread
enzym
mutat
involv
adapt
differ
host
cell
could
lead
unexpect
surpris
replac
structur
gene
yf
flavivirus
might
alter
tropism
potenti
replic
unanticip
tissu
examin
individu
hand
signific
advantag
live
vaccin
includ
develop
rapid
durabl
humor
cellmedi
immun
respons
close
mimic
direct
wildtyp
viru
insuffici
data
recommend
use
protect
human
hors
develop
wn
vaccin
follow
path
drawn
develop
liveattenu
yfje
chimer
vaccin
chimerivaxj
twoplasmid
system
use
develop
chimerivaxj
util
replac
sequenc
je
prm
e
gene
wn
strain
viru
fig
result
virion
envelop
wn
contain
structur
involv
viruscel
attach
viru
intern
antigen
determin
neutral
epitop
tcell
mediat
immun
capsid
protein
nonstructur
protein
nontransl
termini
utr
respons
viru
replic
remain
yf
vaccin
like
chimerivaxj
chimer
yfwn
viru
replic
tissu
cultur
titer
excess
log
plaqueform
unit
pfu
ml
chimer
viru
expect
replic
effici
host
well
provid
protect
immun
wn
viru
crohn
diseas
chronic
inflammatori
diseas
primarili
involv
small
larg
intestin
affect
part
digest
system
well
cytotox
cell
cell
kill
cell
cytotox
cell
mhc
class
irestrict
cell
cell
also
kill
case
cytotox
cell
import
host
defens
cytosol
pathogen
epitop
refer
site
antigen
recogn
antibodi
epitop
also
call
antigen
determin
tcell
epitop
short
peptid
deriv
protein
antigen
bind
mhc
molecul
recogn
particular
cell
humor
immun
specif
immun
mediat
antibodi
made
humor
immun
respons
mucos
immun
resist
infect
across
mucou
membran
mucos
immun
depend
immun
cell
antibodi
present
line
reproduct
tract
gastrointestin
tract
moist
surfac
bodi
expos
outsid
world
neuroinvas
viru
capabl
invad
central
nervou
system
upon
peripher
inocul
neurovirul
abil
viru
replic
brain
tissu
caus
enceph
revers
genet
strategi
studi
gene
structur
function
sitedirect
mutagenesi
modifi
nucleic
acid
introduc
organ
studi
effect
mutat
rtpcr
revers
transcriptas
polymeras
chain
reaction
pcr
start
templat
rna
impli
need
initi
revers
transcriptas
step
make
dna
templat
follow
separ
convent
pcr
tropism
tissu
host
cell
viru
replic
virion
viru
particl
exist
freeli
outsid
host
cell
neutral
antibodi
first
line
defens
flavivirus
live
vaccin
viru
replic
induc
fast
durabl
respons
cytotox
cell
elimin
virus
abl
establish
intracellular
infect
defens
mechan
recogn
e
protein
well
nonstructur
protein
make
infect
cell
target
cell
kill
exposur
viru
natur
infect
postvaccin
would
lead
rapid
secondari
respons
stronger
primari
respons
increas
crossreact
member
flaviviru
genu
encod
similar
epitop
studi
mice
monkey
conduct
determin
abil
chimerivaxj
vaccin
protect
anim
challeng
challeng
immun
control
monkey
je
viru
perform
intracerebr
ic
inocul
log
pfu
natur
je
infect
occur
peripher
inocul
small
dose
viru
mosquito
saliva
estim
vitro
method
femal
mosquito
releas
log
pfu
blood
feed
typic
rhesu
monkey
develop
brain
infect
enceph
peripher
je
viru
inocul
ic
inocul
diseas
model
thu
use
vaccin
efficaci
test
therefor
rel
peripher
natur
infect
ic
inocul
log
pfu
sever
test
protect
chimeravaxj
immun
rhesu
develop
high
titer
neutral
antibodi
subcutan
vaccin
follow
ic
challeng
wildtyp
je
viru
vaccin
monkey
protect
viremia
clinic
enceph
provid
clear
evid
vaccin
efficaci
neurotrop
natur
virus
might
lead
enceph
human
safeti
live
je
wn
vaccin
care
address
flaviviru
genom
replic
lack
proofread
activ
result
signific
rate
mutat
exampl
one
singl
codon
alter
gaa
glutam
acid
aaa
lysin
envelop
protein
gene
markedli
reduc
virul
je
viru
isol
studi
genet
stabil
chimerivax
vaccin
construct
viru
pass
six
time
brain
tissu
mice
time
cell
cultur
chimerivaxj
vaccin
genom
attenu
phenotyp
shown
stabl
passag
molecular
basi
attenu
chimerivaxj
vaccin
studi
systemat
mutagenesi
neurovirul
je
strain
attenu
je
strain
compar
sequenc
analysi
amino
acid
residu
prme
sequenc
vaccin
implic
virul
revert
elucid
multipl
attenu
determin
e
gene
provid
rational
develop
chimer
wn
vaccin
principl
attenu
phenotyp
safeti
profil
chimerivaxj
viru
base
deriv
genom
proven
vaccin
strain
ie
yf
je
liveattenu
je
vaccin
use
china
possess
excel
safeti
record
basi
attenu
lie
within
genom
sequenc
rna
virus
sequenc
chang
affect
phenotyp
alter
function
gene
product
secondari
structur
integr
rna
molecul
effect
sequenc
prme
gene
je
virul
phenotyp
reveal
follow
mous
studi
compar
chimerivaxj
correspond
neurovirul
yfje
nakayama
construct
studi
show
lack
neurovirul
chimerivaxj
rel
nakayama
construct
yf
vaccin
control
e
protein
wildtyp
attenu
je
strain
differ
ten
amino
acid
residu
tabl
twoplasmid
system
encod
yfwn
chimer
vaccin
plasmid
wn
premembran
envelop
protein
gene
prme
encod
utr
yellow
fever
capsid
yfc
west
nile
viru
prm
gray
end
e
blue
end
yellow
fever
utr
plasmid
wn
encod
second
half
e
blue
nonstructur
gene
yellow
fever
west
nile
prme
gene
fragment
amplifi
rtpcr
subclon
twoplasmid
system
overlapextens
pcr
silent
eag
bsp
ei
site
introduc
vitro
ligat
step
necessari
creat
fulllength
cdna
vitro
transcript
nake
rna
initi
product
infect
transfect
vero
cell
line
wherea
residu
order
contribut
measur
increas
neurovirul
wn
viru
member
je
antigen
complex
subgroup
close
relat
flavivirus
defin
crossneutr
sequenc
similar
e
protein
wn
je
shown
fig
high
degre
similar
hypothes
introduct
mutat
link
attenu
je
also
attenu
chimerivaxwn
chimerivaxwn
approach
systemat
mutat
sequenc
wildtyp
wn
strain
e
protein
assess
effect
singl
mutat
equival
residu
addit
mutagenesi
target
could
consid
outcom
flaviviru
studi
mutat
vicin
associ
alter
viru
tropism
chang
virul
posit
might
play
signific
role
either
glycin
g
glutam
acid
e
sever
virul
je
strain
analyz
posit
repres
conserv
substitut
transmembran
region
e
protein
littl
chanc
major
effect
tyrosin
posit
tabl
might
contribut
attenu
chimerivaxwn
present
configur
hypothesi
test
target
mutat
isoleucin
test
increas
neurovirul
eventu
combinatori
mutat
studi
defin
attenu
vaccin
surprisingli
chimer
chimerivaxwn
construct
contain
wildtyp
wn
prme
found
significantli
less
neurovirul
yf
vaccin
young
adult
mice
five
per
group
inocul
ic
grade
dose
log
pfu
result
scatter
death
rang
mortal
without
clear
dose
effect
perhap
owe
suscept
model
use
contrast
yf
lethal
dose
log
pfu
mous
model
addit
chimerivaxwn
lost
neuroinvas
properti
typic
wildtyp
wn
viru
replic
brain
tissu
viremia
level
moribund
anim
measur
howev
averag
surviv
time
nine
day
similar
virus
data
suggest
sequenceunmodifi
chimera
might
vaccin
candid
ultim
safeti
live
attenu
chimerivaxwn
reli
sequenc
stabil
genom
particularli
e
protein
amino
acid
posit
identifi
play
role
attenu
biotech
compani
baxterimmuno
austria
initi
effort
develop
formalininactiv
human
vaccin
fort
dodg
anim
health
usa
initi
develop
formalininactiv
dna
plasmid
vaccin
hors
dna
technolog
develop
center
diseas
control
prevent
ft
collin
co
usa
studi
hors
colorado
state
univers
demonstr
protect
viru
challeng
lustig
et
al
produc
live
attenu
wn
viru
isol
deriv
empir
passag
wildtyp
strain
aed
aegypti
mosquito
cell
one
dose
attenu
viru
show
protect
mice
gees
ic
inocul
diseas
model
challeng
homolog
wildtyp
wn
ref
formalininactiv
wn
vaccin
work
effect
je
howev
requir
multipl
dose
efficaci
protect
vaccin
would
benefici
immedi
threat
epidem
diseas
dna
vaccin
express
wn
prme
gene
might
protect
hors
like
requir
multipl
dose
consid
possibl
spontan
virul
revers
owe
rel
high
mutat
rate
rna
virus
live
attenu
fulllength
wn
vaccin
safe
wn
prme
dna
vaccin
furthermor
wn
prme
dna
vaccin
produc
antibodi
wn
ident
conserv
residu
shown
blue
green
respect
ident
predict
clustal
w
align
red
arrow
map
locat
ten
amino
acid
residu
distinguish
virul
je
nakayama
strain
e
protein
see
tabl
review
membran
protein
encod
plasmid
thu
respons
nonstructur
viral
gene
typic
natur
wn
infect
absent
facilit
screen
trade
hors
exist
antibodi
detect
method
chimer
live
vaccin
chimerivaxwn
encod
nonstructur
gene
yf
might
effect
hors
dna
vaccin
howev
determin
whether
vaccin
replic
prove
effect
need
wn
viru
vaccin
defin
progress
wn
outbreak
promis
candid
human
vaccin
includ
old
technolog
formalininactiv
viru
vaccin
live
chimer
vaccin
ration
approach
use
creat
safe
recombin
vaccin
live
vaccin
rapidli
elicit
immun
singl
dose
would
much
prefer
multidos
product
use
impend
epidem
surveil
bird
mosquito
provid
brief
warn
viru
activ
risk
human
diseas
ecolog
wn
viru
western
hemispher
still
evolv
least
five
speci
mosquito
found
compet
vector
experiment
transmiss
studi
wn
strain
understand
basic
transmiss
cycl
wn
bird
mosquito
need
implement
proper
control
mechan
ultim
clear
definit
risk
associ
wn
viru
epidem
might
help
creat
suffici
prevent
measur
avoid
use
vaccin
meantim
long
outbreak
continu
occur
predominantli
urban
area
media
attent
ubiquit
system
reli
sight
dead
crow
forecast
potenti
wn
epidem
need
develop
vaccin
continu
